Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Conditions:   HER2-positive Breast Cancer;   Breast Cancer Metastatic Interventions:   Drug: Palbociclib 75mg;   Drug: Letrozole 2.5mg;   Drug: T-DM1;   Drug: Palbociclib 100mg;   Drug: Palbociclib 125mg;   Drug: Palbociclib Sponsors:   University of Kansas Medical Center;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials